# Novo US (Novo Nordisk US) > Novo is a global healthcare company that believes lasting health starts now. For over a century, Novo has combined leading scientific expertise with a deep understanding of people's lives. Novo develops treatments and support that help millions of people make progress they can see, feel and sustain now and in the future. Every day, over 67,000 employees around the world advance Novo's purpose to drive change for lasting health. Through our partnerships, programs and investments, Novo is working to prevent disease, expand access to treatments and reduce our environmental impact to help even more people live healthier lives. In the United States, Novo has a 40-year presence, is headquartered in New Jersey and employs approximately 10,000 people. ## About the Company - [Who We Are](https://www.novonordisk-us.com/about/who-we-are.html): Overview of Novo US, company heritage, U.S. presence, and core mission in treating serious chronic conditions. - [What We Do](https://www.novonordisk-us.com/about/what-we-do.html): Summary of Novo's commercial operations, therapeutic innovations, and healthcare initiatives across the United States. - [Our Executive Team](https://www.novonordisk-us.com/about/our-executive-team.html): Biographies and corporate leadership details for Novo US executive management. - [Positive Environmental Impact](https://www.novonordisk-us.com/sustainable-business/zero-environmental-impact.html): Novo's strategy for positive environmental impact, carbon reduction goals, and sustainable business practices. - [Our Scientific Approach](https://www.novonordisk-us.com/partnering-and-innovation/our-scientific-approach.html): Insights into Novo's R&D philosophy, therapeutic focus, and technological innovation in drug discovery. - [Careers at Novo](https://www.novonordisk-us.com/careers/careers-at-novo.html): Job opportunities, early career programs, manufacturing sites, workplace culture, and employment in the United States. - [Contact Us](https://www.novonordisk-us.com/contact-us.html): Official contact channels, U.S. headquarters address (Plainsboro, NJ), customer support phone lines, and adverse event reporting. ## Therapy Areas - [Diabetes](https://www.novonordisk-us.com/disease-areas/diabetes.html): Disease overview and research focus on type 1 and type 2 diabetes treatments. - [Obesity](https://www.novonordisk-us.com/disease-areas/obesity.html): Clinical understanding, disease education, support options and treatments for chronic weight management. - [Hemophilia](https://www.novonordisk-us.com/disease-areas/hemophilia.html): Disease overview and therapeutic advances for hemophilia A, hemophilia B, and rare bleeding disorders. - [Growth Disorders](https://www.novonordisk-us.com/disease-areas/growth-disorders.html): Scientific focus on growth hormone deficiency (GHD) and related rare endocrine diseases. - [Cardiovascular Disease](https://www.novonordisk-us.com/disease-areas/cardiovascular-disease.html): Disease overview of common types of cardiovascular disease. - [MASH (Metabolic Dysfunction-Associated Steatohepatitis)](https://www.novonordisk-us.com/disease-areas/mash.html): Signs and symptoms of metabolic dysfunction-associated steatohepatitis (MASH), a liver disease. - [Sickle Cell Disease](https://www.novonordisk-us.com/disease-areas/sickle-cell-disease.html): Therapeutic initiatives and scientific development addressing sickle cell disease, a rare genetic disorder. - [Primary Hyperoxaluria](https://www.novonordisk-us.com/disease-areas/primary-hyperoxaluria.html): Disease overview and research into rare genetic metabolic disorders affecting kidney function. ## Products - [Diabetes Products](https://www.novonordisk-us.com/products/diabetes.html): Information and prescribing details for Novo's portfolio of insulins, GLP-1 medicines, and glucagon therapies. - [Obesity Products](https://www.novonordisk-us.com/products/obesity.html): Information and prescribing details for Novo's portfolio of chronic weight management prescription medicines. - [Rare Disease Products](https://www.novonordisk-us.com/products/raredisease.html): Information and prescribing details for Novo's portfolio of rare blood disorder and rare endocrine treatments. - [Safe Product Disposal](https://www.novonordisk-us.com/products/product-disposal.html): Guidelines and resources for safe sharps and medication disposal for patients in the United States. ## Resources for Patients, Healthcare Professionals, and Researchers - [Patient Access and Affordability](https://www.novonordisk-us.com/patient-help/access-and-affordability.html): Patient support options, savings card registration, insurance coverage assistance, NovoCare, NovoCare Pharmacy, Medicare GLP-1 Bridge and Patient Assistance Program (PAP) details. - [Patient Resources and Support](https://www.novonordisk-us.com/patient-help/resources-and-support.html): Educational tools, patient support, lifestyle guidance, and disease management resources. - [Healthcare Professionals Resources](https://www.novonordisk-us.com/healthcare-professionals/resources-and-support.html): Dedicated portal providing U.S. clinicians with prescribing info, clinical trial data, and medical education. - [Open Innovation](https://www.novonordisk-us.com/partnering-and-innovation/open-innovation.html): Platform enabling external researchers and biotechs to collaborate and access preclinical assets and compounds. - [Investigator-Sponsored Studies (ISS)](https://www.novonordisk-us.com/partnering-and-innovation/investigator-sponsored-studies.html): Guidelines and application portal for independent researchers seeking funding or compound support from Novo. ## Media - [Latest News](https://www.novonordisk-us.com/media/latest-news.html): Recent press releases, FDA regulatory updates, clinical trial results, and corporate announcements. - [News Archive](https://www.novonordisk-us.com/media/press-releases.html): Repository of historical press releases and media announcements from Novo US. - [Contact News Media](https://www.novonordisk-us.com/media/contact-news-media.html): Contact directory for journalists and media outlets seeking information from Novo US Media Relations. - [Media Library](https://www.novonordisk-us.com/media/media-library.html): High-resolution corporate logos, company heritage imagery, and manufacturing photos. - [Wegovy® Media Kit](https://www.novonordisk-us.com/media/media-library/wegovy.html): Media kit, product imagery, news backgrounders, and broadcast-quality b-roll for Wegovy®. - [Ozempic® Media Kit](https://www.novonordisk-us.com/media/media-library/ozempic.html): Media kit, product imagery, news backgrounders, and broadcast-quality b-roll for Ozempic®. - [Awiqli® Media Kit](https://www.novonordisk-us.com/media/media-library/awiqli.html): Media kit, product imagery, and news backgrounders for Awiqli® (once-weekly basal insulin). - [Sogroya® Media Kit](https://www.novonordisk-us.com/media/media-library/sogroya.html): Media kit, product imagery, and news backgrounders for Sogroya® (somapacitan-beco) growth hormone therapy. - [Alhemo® Media Kit](https://www.novonordisk-us.com/media/media-library/alhemo.html): Media kit, product imagery, and news backgrounders for Alhemo®. ## Optional & Additional Resources - [Perspectives](https://www.novonordisk-us.com/about/perspectives.html): Thought leadership, commentary, and opinion pieces on healthcare policy, chronic disease innovation, and patient advocacy. - [Safety Reporting](https://www.novonordisk-us.com/patient-help/safety-reporting.html): Instructions and official channels for reporting adverse events, side effects, or product complaints in the U.S. - [Investors](https://www.novonordisk-us.com/investors.html): Financial reports, stock information, quarterly earnings presentations, and investor relations contacts. - [Product Patents](https://www.novonordisk-us.com/products/product-patents.html): Comprehensive listing of U.S. patents associated with Novo's prescription medicines and device innovations. - [Privacy Notice](https://www.novonordisk-us.com/privacy-notice.html): Information on U.S. privacy practices, state privacy rights (e.g., CCPA/CPRA), and personal data collection policies. - [XML Sitemap](https://www.novonordisk-us.com/sitemap.xml): Complete machine-readable XML sitemap index of all public, canonical pages on the Novo US website.